🇺🇸 FDA
Patent

US 11919910

Spiropyrrolidine derived antiviral agents

granted A61PA61P31/14

Quick answer

US patent 11919910 (Spiropyrrolidine derived antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P31/14